Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasuhiro Imaeda
Observed names:
Imaeda, Yasuhiro,
Y. IMAEDA,
今枝泰宏
Institution:
Takeda (Japan)
Observed institutions:
BC Cancer Agency,
University of British Columbia,
Kyoto University,
University of Michigan,
Kyoto University Institute for Chemical Research,
Takeda (Japan)
show all 6
ORCID:
0000-0002-3173-9751
Observed ORCID:
0000-0002-3173-9751
OpenAlex ID:
A5037570394
In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
2017
·
Nobumichi Ohoka
, Keiichiro Okuhira
, et al.
·
Journal of Biological Chemistry
·
249
PDF
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
2018
·
Kazuhide Nakayama
, Magdalena M. Szewczyk
, et al.
·
Oncotarget
·
167
PDF
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
2017
·
Norihito Shibata
, Katsunori Nagai
, et al.
·
Journal of Medicinal Chemistry
·
148
Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins
2013
·
Yuta Tanaka
, Katsuji Aikawa
, et al.
·
Journal of Medicinal Chemistry
·
117
Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation
2018
·
Nobumichi Ohoka
, Yoko Morita
, et al.
·
Journal of Biological Chemistry
·
111
PDF
Development of protein degradation inducers of oncogenic BCR ‐ ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
2017
·
Norihito Shibata
, Naoki Miyamoto
, et al.
·
Cancer Science
·
106
PDF
Discovery of 3-Benzyl-1-( trans -4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors
2018
·
Masahiro Ito
, Toshio Tanaka
, et al.
·
Journal of Medicinal Chemistry
·
73
A model of antimycin A binding based on structure-activity studies of synthetic antimycin A analogues
1995
·
Hideto Miyoshi
, Nobuya Tokutake
, et al.
·
Biochimica et Biophysica Acta (BBA) - Bioenergetics
·
67
PDF
Discovery of a B-Cell Lymphoma 6 Protein–Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach
2017
·
Yusuke Kamada
, Nozomu Sakai
, et al.
·
Journal of Medicinal Chemistry
·
58
Discovery of a Tetrahydropyrimidin-2(1H)-one Derivative (TAK-442) as a Potent, Selective, and Orally Active Factor Xa Inhibitor
2010
·
Takuya Fujimoto
, Yasuhiro Imaeda
, et al.
·
Journal of Medicinal Chemistry
·
57
Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay
2017
·
Misa Iwatani-Yoshihara
, Masahiro Ito
, et al.
·
ACS Chemical Biology
·
46
Discovery of selective ATP-competitive eIF4A3 inhibitors
2017
·
Masahiro Ito
, Misa Iwatani
, et al.
·
Bioorganic & Medicinal Chemistry
·
42
Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design
2017
·
Takeshi Yasui
, Takeshi Yamamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
41
PDF
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors
2017
·
Masahiro Ito
, Toshio Tanaka
, et al.
·
Journal of Medicinal Chemistry
·
40
Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship
2016
·
Kotaro Sakamoto
, Satoshi Sogabe
, et al.
·
Biochemical and Biophysical Research Communications
·
38
Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor
2016
·
Yasuhiro Imaeda
, Hidekazu Tokuhara
, et al.
·
ACS Medicinal Chemistry Letters
·
30
PDF
Discovery of Imidazo[1,5-c]imidazol-3-ones: Weakly Basic, Orally Active Factor Xa Inhibitors
2008
·
Yasuhiro Imaeda
, Takanobu Kuroita
, et al.
·
Journal of Medicinal Chemistry
·
30
Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo
2002
·
Akira Hori
, Yasuhiro Imaeda
, et al.
·
Cancer Letters
·
29
Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein–Protein Interaction Interface
2018
·
Tomoya Sameshima
, Takeshi Yamamoto
, et al.
·
Biochemistry
·
27
Discovery of piperazinylimidazo[1,2-a]pyridines as novel S4 binding elements for orally active Factor Xa inhibitors
2007
·
Yasuhiro Imaeda
, Tetsuji Kawamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
19
Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays
2020
·
Shoichi Nakao
, Masahiro Nogami
, et al.
·
Biochemical and Biophysical Research Communications
·
15
PDF
Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors
2017
·
Ryo Mizojiri
, Daisuke Nakata
, et al.
·
ACS Medicinal Chemistry Letters
·
15
Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors
2016
·
Yasuhiro Imaeda
, Michiko Tawada
, et al.
·
Bioorganic & Medicinal Chemistry
·
14
Discovery of sulfonylalkylamides: A new class of orally active factor Xa inhibitors
2007
·
Yasuhiro Imaeda
, Toshio Miyawaki
, et al.
·
Bioorganic & Medicinal Chemistry
·
13
Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten
1998
·
Masaaki Sawa
, Yasuhiro Imaeda
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
12
Show more works
View as search
Works count:
49
Citation count:
1,613
H-index:
19
I10-index:
28
Year
Topic
Type